IDEX Reports Strong Q1 2026 Earnings with Organic Sales Growth and Margin Expansion
IDEX (IEX) reported strong Q1 2026 results, including 5% organic sales growth and a 26% adjusted EBITDA margin, up 50 basis points year-over-year. The company raised its full-year 2026 financial outlook due to strong performance across segments and increased orders, particularly in the Health & Science Technologies segment.
Tickers: $IEX
Topics: Earnings Call EBITDA Margin Financial Performance Order Growth Q1 2026 Results Sales Growth